363 related articles for article (PubMed ID: 21854453)
1. Pneumocystis jiroveci pneumonia prophylaxis during maintenance therapy influences methotrexate/6-mercaptopurine dosing but not event-free survival for childhood acute lymphoblastic leukemia.
Levinsen M; Shabaneh D; Bohnstedt C; Harila-Saari A; Jonsson OG; Kanerva J; Lindblom A; Lund B; Andersen EW; Schmiegelow K;
Eur J Haematol; 2012 Jan; 88(1):78-86. PubMed ID: 21854453
[TBL] [Abstract][Full Text] [Related]
2. Pneumocystis carinii pneumonia during maintenance treatment of childhood acute lymphoblastic leukemia.
Poulsen A; Demeny AK; Bang Plum C; Gjerum Nielsen K; Schmiegelow K
Med Pediatr Oncol; 2001 Jul; 37(1):20-3. PubMed ID: 11466718
[TBL] [Abstract][Full Text] [Related]
3. Twice weekly Pneumocystis jiroveci pneumonia prophylaxis with trimethoprim-sulfamethoxazole in pediatric patients with acute lymphoblastic leukemia.
Agrawal AK; Chang PP; Feusner J
J Pediatr Hematol Oncol; 2011 Jan; 33(1):e1-4. PubMed ID: 21102354
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Dapsone Versus Trimethoprim/Sulfamethoxazol for Pneumocystis Jiroveci Prophylaxis in Children With Acute Lymphoblastic Leukemia With a Background of Ethnic Neutropenia.
Nazir HF; Elshinawy M; AlRawas A; Khater D; Zadjaly S; Wali Y
J Pediatr Hematol Oncol; 2017 Apr; 39(3):203-208. PubMed ID: 28234744
[TBL] [Abstract][Full Text] [Related]
5. Successful prophylaxis against Pneumocystis carinii pneumonia in HIV-infected children using smaller than recommended dosages of trimethoprim-sulfamethoxazole.
Fisher RG; Nageswaran S; Valentine ME; McKinney RE
AIDS Patient Care STDS; 2001 May; 15(5):263-9. PubMed ID: 11530767
[TBL] [Abstract][Full Text] [Related]
6. Successful Pneumocystis carinii pneumonia prophylaxis using aerosolized pentamidine in children with acute leukemia.
Weinthal J; Frost JD; Briones G; Cairo MS
J Clin Oncol; 1994 Jan; 12(1):136-40. PubMed ID: 8270969
[TBL] [Abstract][Full Text] [Related]
7. The circadian schedule for childhood acute lymphoblastic leukemia maintenance therapy does not influence event-free survival in the NOPHO ALL92 protocol.
Clemmensen KK; Christensen RH; Shabaneh DN; Harila-Saari A; Heyman M; Jonsson OG; Wesenberg F; Rosthøj S; Schmiegelow K;
Pediatr Blood Cancer; 2014 Apr; 61(4):653-8. PubMed ID: 24265159
[TBL] [Abstract][Full Text] [Related]
8. A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation.
Colby C; McAfee S; Sackstein R; Finkelstein D; Fishman J; Spitzer T
Bone Marrow Transplant; 1999 Oct; 24(8):897-902. PubMed ID: 10516703
[TBL] [Abstract][Full Text] [Related]
9. Efficacies of atovaquone, pentamidine, and trimethoprim/sulfamethoxazole for the prevention of Pneumocystis jirovecii pneumonia in patients with connective tissue diseases.
Kitazawa T; Seo K; Yoshino Y; Asako K; Kikuchi H; Kono H; Ota Y
J Infect Chemother; 2019 May; 25(5):351-354. PubMed ID: 30711257
[TBL] [Abstract][Full Text] [Related]
10. Pneumocystis carinii pneumonia prophylaxis and early clinical manifestations of severe perinatal human immunodeficiency virus type 1 infection. Northern California Pediatric HIV Consortium.
Maldonado YA; Araneta RG; Hersh AL
Pediatr Infect Dis J; 1998 May; 17(5):398-402. PubMed ID: 9613653
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic Trimethoprim-Sulfamethoxazole Does Not Affect Pharmacokinetics or Pharmacodynamics of Methotrexate.
Watts CS; Sciasci JN; Pauley JL; Panetta JC; Pei D; Cheng C; Christensen CM; Mikkelsen TS; Pui CH; Jeha S; Relling MV
J Pediatr Hematol Oncol; 2016 Aug; 38(6):449-52. PubMed ID: 27322715
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation.
Prasad GVR; Beckley J; Mathur M; Gunasekaran M; Nash MM; Rapi L; Huang M; Zaltzman JS
BMC Infect Dis; 2019 Apr; 19(1):311. PubMed ID: 30953458
[TBL] [Abstract][Full Text] [Related]
13. Tolerability of low-dose sulfamethoxazole/trimethoprim for Pneumocystis jirovecii pneumonia prophylaxis in kidney transplant recipients.
Zmarlicka M; Martin ST; Cardwell SM; Nailor MD
Prog Transplant; 2015 Sep; 25(3):210-6. PubMed ID: 26308779
[TBL] [Abstract][Full Text] [Related]
14. The impact of trimethoprim-sulfamethoxazole as Pneumocystis jiroveci pneumonia prophylaxis on the occurrence of asymptomatic bacteriuria and urinary tract infections among renal allograft recipients: a retrospective before-after study.
Singh R; Bemelman FJ; Hodiamont CJ; Idu MM; Ten Berge IJ; Geerlings SE
BMC Infect Dis; 2016 Feb; 16():90. PubMed ID: 26912326
[TBL] [Abstract][Full Text] [Related]
15. Infections during induction therapy for children with acute lymphoblastic leukemia. the role of sulfamethoxazole-trimethoprim (SMX-TMP) prophylaxis.
Rungoe C; Malchau EL; Larsen LN; Schroeder H
Pediatr Blood Cancer; 2010 Aug; 55(2):304-8. PubMed ID: 20583218
[TBL] [Abstract][Full Text] [Related]
16. A dose-escalation regimen of trimethoprim-sulfamethoxazole is tolerable for prophylaxis against Pneumocystis jiroveci pneumonia in rheumatic diseases.
Takenaka K; Komiya Y; Ota M; Yamazaki H; Nagasaka K
Mod Rheumatol; 2013 Jul; 23(4):752-8. PubMed ID: 22907597
[TBL] [Abstract][Full Text] [Related]
17. [Pneumocystis jiroveci pneumonia as a complication of glucocorticoid therapy for interstitial pneumonia].
Enomoto T; Azuma A; Matsumoto A; Nei T; Hiramatsu K; Abe S; Usuki J; Kudoh S
Nihon Kokyuki Gakkai Zasshi; 2005 Dec; 43(12):725-30. PubMed ID: 16457333
[TBL] [Abstract][Full Text] [Related]
18. Antibacterial prophylaxis with trimethoprim-sulfamethoxazole during induction treatment for acute lymphoblastic leukemia.
Schrøder H; Agger KE; Rosthøj S; Carlsen NT; Schmiegelow K
Dan Med Bull; 2001 Nov; 48(4):275-7. PubMed ID: 11767129
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Pneumocystis carinii pneumonia in patients with AIDS.
Wordell CJ; Hauptman SP
Clin Pharm; 1988 Jul; 7(7):514-27. PubMed ID: 3138063
[TBL] [Abstract][Full Text] [Related]
20. Reduced toxicity with gradual initiation of trimethoprim-sulfamethoxazole as primary prophylaxis for Pneumocystis carinii pneumonia: AIDS Clinical Trials Group 268.
Para MF; Finkelstein D; Becker S; Dohn M; Walawander A; Black JR
J Acquir Immune Defic Syndr; 2000 Aug; 24(4):337-43. PubMed ID: 11015150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
